This week The Block Firm, partnering with our good friends at Anderson & Shah, filed a class action (read complaint here) against the manufacturer of a generic form of Cymbalta (duloxetine). The defendant, Breckenridge Pharmaceutical, Inc., recalled more than 50 million pills because they were contaminated with nitrosamines. Nitrosamines are a known byproduct of unsafe pharmaceutical manufacturing practices. Scientists consider nitrosamines to be “high potency mutagenic carcinogens,” and their presence in Breckenridge’s pills is unacceptable. On behalf of the class, The Block Firm will be seeking economic damages because patients would have never bought these pills had Breckenridge revealed the contamination—the pills never should have been on the market.
This case follows The Block Firm’s recent successful prosecution of a nationwide class action against a maker of adulterated drugs, which resulted in a $46.5 million settlement. We take pride in using the tools of private civil enforcement to help ensure the integrity of the drug supply system. If you’ve been injured or cheated by the makers of defective drugs, please contact us to discuss your options.
